个人简介
Education Experience:
2001-2004 Master of Engineering Pattern Recognition and Intelligence System Tianjin University, CN
2004-2007 Doctor of Engineering Medicinal Chemistry Tianjin University CN
Professional Experience:
2007-今 lecturer Tanjin University , China
1995-2001 Physician Laboratorian of Center for Disease Control and Prevention, Hexi District, Tianjin
Honors and Awards:
魏静,四乙酰核糖和二乙酰阿昔洛韦合成的新工艺,天津市人民政府,科技进步奖,二等奖,2009。(赵康、陈维瑜、魏静、杜云飞、王松青、苏艳芳、张秀东、陈炎泉)
魏静,第十三届“挑战杯”天津市大学生课外学术科技作品竞赛优秀指导教师,天津市委员会、天津市科学技术委员会、天津市教育工作委员会等,2015。
研究领域
Wei’s research addresses mechanisms of drug activity with associated drug design. Computational approaches (e.g., molecular docking, pharmacophore modeling, quantitative structure-activity relationship (QSAR), molecular dynamics) are used to identify and characterize putative ligand binding sites, elucidate binding mechanisms, and guide rational design of potentially new drugs.
近期论文
查看导师新发文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
Distinct binding mode of BAFF antagonist antibodies belimumab and tabalumab, analyzed by computer simulation
Jiang Yaxin,Sun Jian,Wei Jing
ISSN:1610-2940 2022
Container-title:Journal of Molecular Modeling
New therapeutic strategies based on biasing IL-2 mutants for cancers and autoimmune diseases
Dongfu Jin , Yaxin Jiang , Lu Chang , Jing Wei , Jian Sun
International Immunopharmacology,Volume 110, September 2022, 108935
Analysis of the molecular mechanism of SARS-CoV-2 antibodies
Jin Dongfu,Wei Jing,Sun Jian
Page:45-52 ISSN:0006-291X 2021
Container-title:Biochemical and Biophysical Research Communications
Roles of TGF-β signaling pathway in tumor microenvirionment and cancer therapy
Zhao Haodi,Wei Jing,Sun Jian
Page:107101 ISSN:1567-5769 2020
Container-title:International Immunopharmacology
Study on the Mechanism of Selective Interaction of BR3 and BCMA with BAFF and APRIL
Protein & Peptide Letters
2020-11-16 | Journal article
DOI: 10.2174/0929866527666200413101757
CONTRIBUTORS: Luoman Li; Yaxin Jiang; LiLi Su; Deming Feng; Jing Wei; Jian Sun
Construction of small molecular CTLA4 analogs with CD80-binding affinity
Liu Fang,Su LiLi,Chen Ziteng,Feng Deming,Wei Jing,Sun Jian
Page:694-700 ISSN:0006-291X 2019
Container-title:Biochemical and Biophysical Research Communications
In vitro and in vivo cancer cell apoptosis triggered by competitive binding of Cinchona alkaloids to the RING domain of TRAF6
Yonghao Qi, Xuan Zhao, Jiaying Chen, Ambara R. Pradipta, Jing Wei, Haihua Ruan, Lijun Zhou, Richard P. Hsung & Katsunori Tanaka
Bioscience, Biotechnology, and Biochemistry, Volume 83, Issue 6, 3 June 2019, Pages 1011–1026, https://doi.org/10.1080/09168451.2018.1559030
Study of the molecular mechanism of interleukin-2 mutein D10 binding to IL-2 receptors by molecular simulations
Zhuo Mao,Xuegang Fu,Zeyun Dong,Xiaodong Jian,Jian Sun &Jing Wei
Pages 973-980 | Received 01 Feb 2018, Accepted 15 Apr 2018, Published online: 27 Apr 2018
Cite this article https://doi.org/10.1080/08927022.2018.1467013
Baicalein decreases uric acid and prevents hyperuricemic nephropathy in mice
Meng Xiaolu,Mao Zhuo,Li Xin,Zhong Dandan,Li Min,Jia Yingli,Wei Jing,Yang Baoxue,Zhou Hong
Page:40305-40317 ISSN:1949-2553 2017
Container-title:Oncotarget
N6-Isopentenyladenosine promoted HeLa cell apoptosis through inhibitions of AKT and transforming growth factor β–activated kinase 1 activation
Miao Li, Yonghao Qi, Jing Wei, Lulu Lu, Xuan Zhao and Lijun Zhou
Page:101042831769596 ISSN:1010-4283 2017
Container-title:Tumor Biology